HK1198012A1
(en )
2015-03-06
Composition for the treatment of fistula
ZA201403795B
(en )
2016-01-27
Formulations for the treatment of diabetes
PT2818482T
(en )
2019-08-06
Pharmaceutical composition for treatment of cancer
PT2824114T
(en )
2019-08-05
Pharmaceutical composition for treatment of cancer
AP2014007533A0
(en )
2014-03-31
Substituted benzylindazoles for use as BUB1 kinaseinhibitors in the treatment of hyperproliferative diseases
PL3378862T3
(en )
2022-05-16
Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of multiple sclerosis
PL2773648T3
(en )
2020-03-31
Pharmaceutical compounds for use in the therapy of clostridium difficile infection
HRP20181761T1
(en )
2018-12-28
New alfentanil composition for the treatment of acute pain
IL231498A0
(en )
2014-04-30
Compositions for the treatment of peripheral ulcers of various origins
HUP1100290A2
(en )
2012-12-28
Combination compositions for the treatment of proliferative diseases
IL234796B
(en )
2018-02-28
Compounds for the treatment of ischemia-reperfusion-related diseases
EP2785342A4
(en )
2015-04-08
Pharmaceutical composition for preventing or treating hypertriglyceridemia or hypertriglyceridemia-associated diseases
HUP1200552A2
(en )
2014-04-28
Pharmaceutical compositions for the treatment of high blood pressure
HUP1100534A2
(en )
2013-04-29
Pharmaceutical composition for the treatment of muscle atrophy
EP2712621A4
(en )
2014-10-29
Pharmaceutical composition for treating hyperproliferative diseases
HUP1100245A2
(en )
2012-11-28
Pharmaceutical composition for the treatment of wounds
AU2011900519A0
(en )
2011-03-03
Drug compositions for the treatment of insomnia
PT2812351T
(en )
2018-08-01
Pharmaceutical composition for the treatment of multiple sclerosis
HK1196953A1
(en )
2014-12-24
Formulations for the treatment of diabetes
HK1157189A1
(en )
2012-06-29
Pharmaceutical composition for the treatment of tumor diseases
GB201207476D0
(en )
2012-06-13
pharmaceutical for the treatment of leishmaniasis